Attached files

file filename
8-K - FORM 8-K - AMERICAN VANGUARD CORPd145434d8k.htm
EX-99.2 - EX-99.2 - AMERICAN VANGUARD CORPd145434dex992.htm

Exhibit 99.1

LOGO

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS FOURTH QUARTER & FULL YEAR 2015 RESULTS

Newport Beach, CA – March 1, 2016 – American Vanguard Corporation (NYSE:AVD) today announced financial results for the fourth quarter and full year ended December 31, 2015.

Fiscal 2015 Fourth Quarter Financial Highlights – versus Fiscal 2014 Fourth Quarter:

 

    Net sales were $84.0 million in Q4 2015 compared to $77.6 million in Q4 2014.

 

    Net income was $3.0 million in Q4 2015 compared to $1.8 million in Q4 2014.

 

    Earnings per diluted share were $0.10 in Q4 2015 versus $0.06 in Q4 2014.

Fiscal 2015 Financial Highlights – versus Fiscal 2014:

 

    Net sales were $289.4 million in FY 2015 compared to $298.6 million in FY 2014.

 

    Net income was $6.6 million in FY 2015 compared to $4.8 million in FY 2014.

 

    Earnings per diluted share were $0.23 in FY 2015 versus $0.17 in FY 2014.

Eric Wintemute, Chairman and CEO of American Vanguard, stated: “Our performance in 2015 reflects continued financial discipline in the face of difficult industry conditions. Low crop commodity prices have led to reduced farmer/grower profitability and cautious purchasing of all crop inputs, including crop protection products. Despite these market conditions, during 2015, American Vanguard recorded net sales only slightly below those of the prior year, maintained a steady level of business in many markets and generated improved profitability overall.”

Mr. Wintemute continued: “Our efforts to control working capital, manage manufacturing costs and reduce operating expenses have led to greater operating efficiency. As a result, we have experienced significant inventory reductions, improved cash generation and have reduced our debt, even while completing two acquisitions that should serve to strengthen our international business.”

Mr. Wintemute concluded: “While the Ag market prospects for 2016 remain challenging, American Vanguard is well-positioned, in a consolidating industry, to pursue its three main objectives: improving market access through additional product acquisitions and collaborative alliances; advancing technological innovation; and driving operational excellence. We believe that these will be the keys to our success and look forward to keeping our investors well informed as we progress in 2016.”


Conference Call

Eric Wintemute, Chairman & CEO, Bob Trogele, EVP & COO and David T. Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 4:30 pm ET / 1:30 pm PT on Tuesday, March 1, 2016. Interested parties may participate in the call by dialing (201) 493-6744. Please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

 

Company Contact:    Investor Representative
American Vanguard Corporation    The Equity Group Inc.
William A. Kuser, Director of Investor Relations    www.theequitygroup.com
(949) 260-1200    Lena Cati
williamk@amvac-chemical.com    Lcati@equityny.com
   (212) 836-9611


CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

Years ended December 31, 2015, 2014 and 2013

(In thousands, except per share data)

 

     2015     2014     2013  

Net sales

   $ 289,382      $ 298,634      $ 381,021   

Cost of sales

     177,480        184,138        209,674   
  

 

 

   

 

 

   

 

 

 

Gross profit

     111,902        114,496        171,347   

Operating expenses

     100,378        107,786        115,612   
  

 

 

   

 

 

   

 

 

 

Operating income

     11,524        6,710        55,735   

Interest expense, net

     2,772        3,153        2,175   

Interest capitalized

     (210     (87     (274
  

 

 

   

 

 

   

 

 

 

Income before provision for income taxes and loss on equity investment

     8,962        3,644        53,834   

Income taxes expense (benefit)

     2,009        (451     18,916   
  

 

 

   

 

 

   

 

 

 

Income before loss on equity investment

     6,953        4,095        34,918   

Less net loss from equity method investment

     (636     (29     (986
  

 

 

   

 

 

   

 

 

 

Net income

     6,317        4,066        33,932   

Add back net loss attributable to non-controlling interest

     274        775        517   
  

 

 

   

 

 

   

 

 

 

Net income attributable to American Vanguard

   $ 6,591      $ 4,841      $ 34,449   
  

 

 

   

 

 

   

 

 

 

Change in fair value of interest rate swaps

     —          340        388   

Foreign currency translation adjustment

     (1,571     (1,262     326   
  

 

 

   

 

 

   

 

 

 

Comprehensive income

   $ 5,020      $ 3,919      $ 35,163   
  

 

 

   

 

 

   

 

 

 

Earnings per common share—basic

   $ .23      $ .17      $ 1.22   
  

 

 

   

 

 

   

 

 

 

Earnings per common share—assuming dilution

   $ .23      $ .17      $ 1.19   
  

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding—basic

     28,673        28,436        28,301   
  

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding—assuming dilution

     29,237        28,912        28,899   
  

 

 

   

 

 

   

 

 

 


CONSOLIDATED BALANCE SHEETS

December 31, 2015 and 2014

(In thousands, except share data)

 

     2015     2014  

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 5,524      $ 4,885   

Receivables:

    

Trade, net of allowance for doubtful accounts of $423 and $166, respectively

     72,835        86,027   

Other

     2,554        2,396   
  

 

 

   

 

 

 
     75,389        88,423   
  

 

 

   

 

 

 

Inventories

     136,477        165,631   

Prepaid expenses

     11,172        13,415   

Income taxes receivable

     168        5,964   

Deferred income tax assets

     8,101        8,731   
  

 

 

   

 

 

 

Total current assets

     236,831        287,049   

Property, plant and equipment, net

     47,972        50,026   

Intangible assets, net of applicable amortization

     129,160        100,211   

Other assets

     29,576        35,035   
  

 

 

   

 

 

 
   $ 443,539      $ 472,321   
  

 

 

   

 

 

 

Liabilities and Stockholders’ Equity

    

Current liabilities:

    

Current installments of other notes payable

   $ 55      $ 71   

Current installments of other liabilities

     514        1,357   

Accounts payable

     15,343        20,411   

Deferred revenue

     8,888        898   

Accrued program costs

     44,371        52,546   

Accrued expenses and other payables

     7,111        5,962   
  

 

 

   

 

 

 

Total current liabilities

     76,282        81,245   

Long-term debt and other notes payable, excluding current installments

     68,321        98,605   

Other liabilities, excluding current installments

     3,054        3,309   

Deferred income tax liabilities

     27,556        28,159   
  

 

 

   

 

 

 

Total liabilities

     175,213        211,318   
  

 

 

   

 

 

 

Commitments and contingent liabilities

    

Stockholders’ equity:

    

Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

     —         —    

Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 31,638,225 shares in 2015 and 31,550,477 shares in 2014

     3,164        3,156   

Additional paid-in capital

     68,534        66,232   

Accumulated other comprehensive loss

     (3,541     (1,970

Retained earnings

     208,507        202,488   
  

 

 

   

 

 

 
     276,664        269,906   

Less treasury stock at cost, 2,450,634 shares in 2015 and in 2014

     (8,269     (8,269
  

 

 

   

 

 

 

American Vanguard Corporation stockholders’ equity

     268,395        261,637   

Non-controlling interest

     (69     (634
  

 

 

   

 

 

 

Total stockholders’ equity

     268,326        261,003   
  

 

 

   

 

 

 
   $ 443,539      $ 472,321   
  

 

 

   

 

 

 


CONSOLIDATED STATEMENTS OF CASH FLOWS

Years ended December 31, 2015, 2014 and 2013

(In thousands)

 

     2015     2014     2013  

Increase cash

      

Cash flows from operating activities:

      

Net income

   $ 6,317      $ 4,066      $ 33,932   

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

      

Depreciation and amortization of fixed and intangible assets

     16,474        16,332        14,845   

Amortization of other long term assets

     5,275        5,811        4,598   

Amortization of discounted liabilities

     140        324        174   

Stock-based compensation

     3,881        4,153        3,819   

Tax effect from the share based compensation

     (23     (300     (440

Increase in deferred income taxes

     27        2,619        2,523   

Operating loss from equity method investment

     629        983        986   

Loss (gain) from dilution of equity method investment

     7        (954     —    

Changes in assets and liabilities associated with operations:

      

Decrease (increase) in net receivables

     13,034        (13,471     2,351   

Decrease (increase) in inventories

     29,154        (25,801     (51,879

Decrease (increase) in income tax receivable/payable, net

     4,872        4,424        (10,961

Decrease (increase) in prepaid expenses and other assets

     2,082        (4,743     (19,733

(Decrease) increase in accounts payable

     (5,068     (19,951     8,252   

Increase (decrease) in deferred revenue

     7,990        (2,890     (16,639

(Decrease) increase in other payables, accrued program costs and expenses

     (6,223     (4,697     21,958   
  

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     78,568        (34,095     (6,214
  

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

      

Capital expenditures

     (6,899     (7,180     (15,260

Investment

     (125     (500     (3,687

Acquisitions of intangible assets

     (36,667     —         —    
  

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (43,691     (7,680     (18,947
  

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

      

Net (payments) borrowings under line of credit agreement

     (30,520     47,850        51,550   

Payments on long-term debt

     —         —         (46,000

Payment on other long-term liabilities

     (1,543     (1,756     (1,831

Tax effect from the share based compensation

     23        300        440   

Decrease in other notes payable

     —         —         (6,154

Repurchases of common stock

     —         (1,531     (1,934

Proceeds from the issuance of common stock (sale of stock under ESPP and exercise of stock options)

     317        1,666        1,610   

Non-controlling interest contribution

     —         299        —    

Payment of cash dividends

     (1,141     (5,672     (4,804
  

 

 

   

 

 

   

 

 

 

Net cash (used in) provided by financing activities

     (32,864     41,156        (7,123
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     2,013        (619     (32,284

Effect of exchange rate changes on cash

     (1,374     (1,176     488   

Cash and cash equivalents at beginning of year

     4,885        6,680        38,476   
  

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of year

   $ 5,524      $ 4,885      $ 6,680   
  

 

 

   

 

 

   

 

 

 

Supplemental cash flow information:

      

Cash paid (received) during the year for:

      

Interest

   $ 2,750      $ 2,298      $ 1,777   
  

 

 

   

 

 

   

 

 

 

Income taxes

   $ (3,697   $ (8,206   $ 25,271